The RevPAR index test in the license is the clause I can't price
$340k of a $4.1M equity raise, LP units, no control, no consent rights beyond the usual major-decision list. The documents came in three pieces: a franchise license agreement, a management agreement whose term outlives the license by four years, and a change of ownership application saying the property improvement plan scope gets set after the franchisor inspects, which happens after closing.
Numbers as handed to me. TTM occupancy 68 percent, ADR $132, RevPAR $89.76, total revenue $3.9M, GOP $1.44M, so a 37 percent margin. Base management fee 3 percent of gross revenue, incentive 15 percent of GOP above a $1.3M hurdle, and the incentive is calculated before the FF&E reserve. Royalty 5.5 percent of rooms revenue plus 3.9 percent for marketing and reservations. The license requires an FF&E reserve of 4 percent of gross revenue. The pro forma carries 2 percent in years one and two with a footnote reading "lender waiver expected." PIP budgeted at $2.6M with a stated range to $2.9M.
The clause I keep going back to: if the hotel's RevPAR index against its comp set falls below 85 percent of fair share for two consecutive calendar years, the franchisor may terminate, with liquidated damages equal to the trailing three-year average royalty multiplied by the lesser of the remaining term or 36 months. Comp set is defined as "a set of comparable hotels selected by franchisor and subject to revision by franchisor from time to time." Current index is 96.
The management agreement has its own two-year performance test. The cure is a written improvement plan accepted by the manager, which reads to me as no cure at all.
So the decision is whether to fund, and if I fund, whether to make the FF&E deferral an amendment condition, because the LP class eats deferred capex whichever way it goes. Sponsor's answer so far is that the deferral is standard and the lender agreed on a call. What am I underweighting here.